Dora Hammerl
R&D Manager at Pan Cancer T- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
NL
Languages
-
English Full professional proficiency
-
Dutch Full professional proficiency
-
German Native or bilingual proficiency
-
French Elementary proficiency
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Experience
-
Pan Cancer T
-
Netherlands
-
Biotechnology Research
-
1 - 100 Employee
-
R&D Manager
-
Jul 2022 - Present
-
-
Co-Founder
-
Sep 2020 - Present
www.pancancer-t.com
-
-
-
Erasmus MC
-
Netherlands
-
Hospitals and Health Care
-
700 & Above Employee
-
Postdoctoral Researcher
-
Jul 2020 - Aug 2022
Counteracting T cell evasive mechanisms in solid tumors Counteracting T cell evasive mechanisms in solid tumors
-
-
-
-
PHD Candidate Immune Therapy and Breast Cancer genomics
-
Jan 2016 - Jun 2020
TCR Engineering, Tumor Immunology and Breast Cancer Genomics and Proteomics. TCR Engineering, Tumor Immunology and Breast Cancer Genomics and Proteomics.
-
-
-
-
Cancer Immunotherapy with immune checkpoint- and metabolic blockers
-
Aug 2014 - Jan 2016
Modulating anti-tumor immune responses by inhibiting the hypoxia-adenosine signaling axis Modulating anti-tumor immune responses by inhibiting the hypoxia-adenosine signaling axis
-
-
-
Leiden University
-
Netherlands
-
Higher Education
-
700 & Above Employee
-
Allosteric Modulation of the Chemokine Receptor CCR2
-
Feb 2013 - Dec 2013
-
-
Education
-
2016 - 2020
Erasmus University Rotterdam
Doctor of Philosophy - PhD, Tumor Immunology -
2013 - 2015
Universiteit Leiden
Master of Science M.Sc), Bio-Pharmaceutical Science -
2008 - 2012
University of Vienna
Bachelor of Science (BSc.), Molekular Biology
Community
You need to have a working account to view this content.
Click here to join now
